methyl 4-(2,6-dimethoxyphenyl)-2,4-dioxobutyrate | 1476068-60-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: methyl 4-(2,6-dimethoxyphenyl)-2,4-dioxobutyrate
• 英文别名: Methyl 4-(2,6-dimethoxyphenyl)-2,4-dioxobutanoate
• CAS: 1476068-60-6
• 化学式: C₁₃H₁₄O₆
• 分子量: 266.251
• InChiKey: SSEUHWJIRKGQFU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  19
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  78.9
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  methyl 4-(2,6-dimethoxyphenyl)-2,4-dioxobutyrate 、 4-溴-2-异丙基苯胺 在 盐酸 、 tin(II) chloride dihdyrate 、 sodium nitrite 作用下， 以 水 、 乙醇 为溶剂， 反应 1.33h， 以56%的产率得到methyl 1-(4-bromo-2-isopropylphenyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carboxylate
  参考文献：
  名称：

  DIAGNOSIS, TREATMENT AND PREVENTION OF NEUROTENSIN RECEPTOR-RELATED CONDITIONS

  摘要：

  本发明描述了一种化合物，其化学式为（I），可用于诊断、治疗或预防与神经肽受体相关的疾病，如肿瘤和血液恶性肿瘤。

  公开号：

  EP3279197A1

文献信息

• DIAGNOSIS, TREATMENT AND PREVENTION OF NEUROTENSIN RECEPTOR-RELATED CONDITIONS
  申请人：Friedrich-Alexander-Universität Erlangen-Nürnberg

  公开号：EP3279197A1

  公开（公告）日：2018-02-07

  The present invention describes a compound of formula (I) which can be used in the diagnosis, treatment or prevention of neurotensin receptor-related conditions such as tumors and hematological malignancies.

  本发明描述了一种化合物，其化学式为（I），可用于诊断、治疗或预防与神经肽受体相关的疾病，如肿瘤和血液恶性肿瘤。
• Diagnosis, treatment and prevention of neurotensin receptor-related conditions
  申请人：Friedrich-Alexander-Universitat Erlangen-Nurnberg

  公开号：US11180511B2

  公开（公告）日：2021-11-23

  The present invention describes a compound of formula (I) which can be used in the diagnosis, treatment or prevention of neurotensin receptor-related conditions such as tumors and hematological malignancies.

  本发明描述了一种式（I）化合物，该化合物可用于诊断、治疗或预防神经紧张素受体相关疾病，如肿瘤和血液恶性肿瘤。
• [EN] COMPOUNDS ACTIVE AT THE NEUROTENSIN RECEPTOR<br/>[FR] COMPOSÉS ACTIFS AU NIVEAU DU RÉCEPTEUR DE LA NEUROTENSINE
  申请人：THOMAS JAMES B

  公开号：WO2011156557A2

  公开（公告）日：2011-12-15

  The present invention relates to compounds that are active at neurotensin receptors and represented by the formula:(I) where the structural variables are defined herein. The compounds can be used for a variety of therapies, including modulating dopamine transmission, treating Parkinsons disease, preventing a relapse to drug seeking, providing an antipsychotic effect, providing neuroprotection, treating pain, treating cancer, and inhibiting cancer progression.
• [EN] DIAGNOSIS, TREATMENT AND PREVENTION OF NEUROTENSIN RECEPTOR-RELATED CONDITIONS<br/>[FR] DIAGNOSTIC, TRAITEMENT ET PRÉVENTION DE TROUBLES LIÉS AU RÉCEPTEUR DE LA NEUROTENSINE
  申请人：UNIV FRIEDRICH ALEXANDER ER

  公开号：WO2018024789A1

  公开（公告）日：2018-02-08

  The present invention describes a compound of formula (I) which can be used in the diagnosis, treatment or prevention of neurotensin receptor-related conditions such as tumors and hematological malignancies.
• Efficient Synthesis of Heterocyclic Neurotensin Receptor Ligands by Microwave-Assisted Aminocarbonylation
  作者：Peter Gmeiner、Christopher Lang

  DOI：10.1055/s-0033-1338497

  日期：——

  Marking the heterocyclic neurotensin receptor antagonist SR142948A as a lead compound, the development of an efficient and a practical synthetic route to heterocyclic aryl carboxamides is reported. Thus, a highly efficient and flexible access to these carboxamides was elaborated by taking advantage of microwave-assisted aminocarbonylation reaction mediated by Mo(CO)(6), Herrmann's palladacycle, [(t-Bu)(3)PH]BF4, and DBU.